Share the CanTreatCOVID study

English (Dr. Andrew Pinto)
English (study team and patient partners)
English (study team and patient partners)
Punjabi ਪੰਜਾਬੀ
Mandarin 中文

CanTreatCOVID relies on volunteers, community partners and organizations to help share the study.

The study aims to identify effective, affordable and evidence-based medications for COVID to help people feel better faster, reduce hospital stays and emergency department visits, and prevent long COVID.

Listed below are different ways to share CanTreatCOVID with friends, family, community, and networks.

You may also order printed materials such as postcards, flyers, and posters using this link or by emailing info@cantreatcovid.org. Together, we can change the future of COVID-19 treatments.

 

Social Media

Sample captions when sharing the study posters on social media:

  • Have you tested positive for COVID with symptoms starting within the last five days? Participate in a research study. Visit CanTreatCOVID.org or call 1-888-888-3308. This research is led by Dr. Andrew Pinto at Unity Health Toronto.
  • Effective and affordable medications to prevent long COVID are urgently needed. Participate in research today. Visit CanTreatCOVID.org or call 1-888-888-3308. This research is led by Dr. @AndrewDPinto and funded by @CIHR_IRSC & @GovCanHealth.
  • Finding effective and affordable medications for COVID starts with you. Visit CanTreatCOVID.org or call 1-888-888-3308. This research is led by Dr. @AndrewDPinto and funded by @CIHR_IRSC & @GovCanHealth.

For Primary Care Providers, Health Centres or Clinics and Pharmacies

You can refer

  • adults who tested positive for COVID with symptoms starting within the last 5 days and
  • aged 18-49 years with one or more chronic condition(s) OR
  • aged 50+ years

How to refer patients?

Ask them to:

Share CanTreatCOVID with your networks and colleagues! If you want printed copies delivered to your site, complete the online form or email info@CanTreatCOVID.org.

Compensation

  • Healthcare providers: $40 for referring potentially eligible participants
  • Patients: up to $120 while in the study

Why partner with us?

  • We will help you save time. You can refer patients to our study, and we will screen if they are eligible to receive COVID medications, including Paxlovid. This research is a randomized controlled trial; if eligible, your patient will be randomized to either active treatment or usual care.
  • This study is the fastest way to answer whether these medications are effective, particularly in a highly vaccinated population.
  • CanTreatCOVID is helping us launch the new Canadian Primary Care Trials Network, finally creating evidence in the real world of primary care.

Posters for Healthcare Providers

Poster Click the links to download
Download the posters

Français

For Community Organizations

You can help your community members know about the study. If eligible to participate, participants will receive personalized care and attention from a healthcare team. To get involved, we invite you to: